Evidence map›Paper›PMID 38661214›Full record

ArticleNucleic acids research2024

TTSBBC: triplex target site biomarkers and barcodes in cancer.

Maya Ylagan, Qi Xu, Jeanne Kowalski

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Maya YlaganDepartment of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX78712, USA.ORCID 0009-0003-8995-2496
Qi XuDepartment of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX78712, USA.ORCID 0000-0002-4646-6936
Jeanne KowalskiDepartment of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX78712, USA.ORCID 0000-0003-3458-3024
The University of Texas at Austin · US

Funding

University of Texas Dell Medical School Research Funds
6 · The paper itself

Abstract

The technology of triplex-forming oligonucleotides (TFOs) provides an approach to manipulate genes at the DNA level. TFOs bind to specific sites on genomic DNA, creating a unique intermolecular triple-helix DNA structure through Hoogsteen hydrogen bonding. This targeting by TFOs is site-specific and the locations TFOs bind are referred to as TFO target sites (TTS). Triplexes have been observed to selectively influence gene expression, homologous recombination, mutations, protein binding, and DNA damage. These sites typically feature a poly-purine sequence in duplex DNA, and the characteristics of these TTS sequences greatly influence the formation of the triplex. We introduce TTSBBC, a novel analysis and visualization platform designed to explore features of TTS sequences to enable users to design and validate TTSs. The web server can be freely accessed at https://kowalski-labapps.dellmed.utexas.edu/TTSBBC/.

Indexed as

DNANeoplasmsBinding SitesBiomarkers, TumorDNA Barcoding, TaxonomicHumansNucleic Acid ConformationOligonucleotidesSoftwareBiomarkers, TumorDNAOligonucleotidestriplex DNA

Identifiers

PMID38661214
PMCPMC11223863
OpenAlexW4395452387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.